Wei Dong, Chen Xi-Ang, Gu Xiao-Dong, Li Peng-Cui, Wei Xiao-Chun
Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China.
Zhongguo Gu Shang. 2021 Sep 25;34(9):879-86. doi: 10.12200/j.issn.1003-0034.2021.09.018.
To evaluate clinical efficacy of arthroscopic with platelet-rich plasma (PRP) in treating meniscus injury.
From January 2015 to December 2019, clinical control study on repair meniscus injury by arthroscopic with PRP between arthroscopic were searched by PubMed, Science Direct, Cochrane library, Chinese Journal Full-text Database, Wanfang and VIP database. Literature screening, data extraction and quality evaluation according to inclusion and exclusion criteria. Visual analogue scale(VAS) of knee joint and Lysholm score at 1, 6 and 12 months after opertaion between two groups were compared, and Western Ontario and McMaster University Osteoarthritis Index (WOMAC) at 3, 6 and 12 months after opertaion between twogroups were also compared.
Totally 9 literatures and 329 patients with meniscal injuries were screened, include 146 patients treated by arthroscopic with PRP and 183 patients treated by arthroscopic. There were no statistical differences in VAS between two groups at 1, 6 and 12 months after opertaion. There were differences in Lysholm score at 1 and 6 months after operation between two groups [=3.85, 95% (1.25, 6.44), <0.05], [=2.88, 95% (0.13, 5.63), <0.05];while there was no difference at 12 months[=5.88, 95%(-8.72, 20.48), =0.43]. There were differneces in WOMAC score at 3 and 6 months after operation between two groups[=-8.07, 95%(-11.17, -4.89), <0.000 01], [=-7.96, 95%(-11.44, -4.48), <0.000 01];and no difference at 12 months after operation[=-6.61, 95% (-16.64, 3.41), >0.05].
Arthroscopic with PRP for repair meniscus injury has short term efficacy of knee function and delay arthritis, while has similar effect in long term clinical efficacy and relieve pain.
评估关节镜联合富血小板血浆(PRP)治疗半月板损伤的临床疗效。
通过检索PubMed、Science Direct、Cochrane图书馆、中国期刊全文数据库、万方数据库和维普数据库,对2015年1月至2019年12月期间关节镜联合PRP修复半月板损伤与单纯关节镜修复半月板损伤的临床对照研究进行检索。根据纳入和排除标准进行文献筛选、数据提取和质量评估。比较两组术后1、6和12个月时膝关节视觉模拟评分(VAS)以及Lysholm评分,同时比较两组术后3、6和12个月时西安大略和麦克马斯特大学骨关节炎指数(WOMAC)。
共筛选出9篇文献,329例半月板损伤患者,其中146例采用关节镜联合PRP治疗,183例采用单纯关节镜治疗。两组术后1、6和12个月时VAS评分无统计学差异。两组术后1个月和6个月时Lysholm评分有差异[=3.85,95%(1.25,6.44),<0.05],[=2.88,95%(0.13,5.63),<0.05];而术后12个月时无差异[=5.88,95%(-8.72,20.48),=0.43]。两组术后3个月和6个月时WOMAC评分有差异[=-8.07,95%(-11.17,-4.89),<0.000 01],[=-7.96,95%(-11.44,-4.48),<0.000 01];术后12个月时无差异[=-6.61,95%(-16.64,3.41),>0.05]。
关节镜联合PRP修复半月板损伤对膝关节功能有短期疗效且可延缓关节炎,而长期临床疗效及缓解疼痛方面效果相似。